Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
May 1, 2000American Journal of HypertensionOpen Access

Heart failure: future treatment approaches

View Full Paper
Ask AI
Bookmark
Share

Population

Patients with chronic heart failure (CHF)

Design

Review

Authors

JCJ. N. Cohn

Discussion

Loading...

Member takes

Overview

Reinforces polypharmacy for chronic HF outcomes; leaves open biomarker-guided personalization in future trials.

Structured PICO

P
Population
Patients with chronic heart failure (CHF)
I
Intervention
Heart failure medical therapies including vasodilators, ACE inhibitors, beta-blockers, spironolactone, digoxin, and ARBs

A historical and forward-looking review of heart failure pharmacotherapy emphasizing the shift towards polypharmacy and the future need for personalized biomarkers.

Cite This Study

J. N. Cohn (2000) studied this question.

synapsesocial.com/papers/6a729e54ac440176ef2ac421https://doi.org/10.1016/s0895-7061(00)00271-5
View Full Paper
Ask AI
Bookmark
Share